A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

This study is testing a new CAR-T cell therapy called CT1190B for people with B-cell non-Hodgkin lymphoma (a type of blood cancer) that has come back or stopped responding to previous treatments. **You may be eligible if...** - You are 18–75 years old - You have been diagnosed with B-cell non-Hodgkin lymphoma - You have already tried at least 2 different treatments that have not worked - You are physically well enough to carry out daily activities (ECOG score 0–1) - You have measurable disease on scans - You are expected to live at least 12 more weeks - You are willing to use effective contraception for 1 year after treatment **You may NOT be eligible if...** - You are pregnant or breastfeeding - You have HIV, active hepatitis B or C, syphilis, or uncontrolled active infection - You have had serious heart problems in the past 6 months - You are currently taking high-dose steroids - You have another active cancer requiring treatment - Side effects from your previous cancer treatment have not fully resolved Talk to your doctor to see if this trial is right for you.